Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-128-3 | CAS number: 630-08-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- other: MAK value
- Adequacy of study:
- weight of evidence
- Rationale for reliability incl. deficiencies:
- other: Maximum Concentration at the workplace (MAK value) of CO; established by the Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, DFG (Deutsche Forschungsgemeinschaft/German Research Association)
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 992
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
Test material
- Reference substance name:
- Carbon monoxide
- EC Number:
- 211-128-3
- EC Name:
- Carbon monoxide
- Cas Number:
- 630-08-0
- Molecular formula:
- CO
- IUPAC Name:
- carbon monooxide
Constituent 1
Results and discussion
Any other information on results incl. tables
Effects of CO in Man
The symptoms of acute CO intoxication with increasing carboxyhaemoglobin (CO-Hb) levels in the blood include: mild headaches, respiratory distress during exercise, reddening of the skin (10-20 % CO-Hb), more severe headaches, frontal pulse, palpitations, dizziness, tinnitus, spots before the eyes, weakness (20 -30 % CO-Hb), exhaustion, nausea, vomiting, sometimes collapse (30 -40 % CO-Hb), increased respiration rate and pulse rate, collapse, unconsciousness (40 -50 % CO-Hb), coma, convulsions, Cheyne-Stokes' respiration (50-60 % CO-Hb), progressive failure of the cardiocirculatory system and respiration, death (60 -70 % CO-Hb) (Lindgren, 1961; Stewart et al., 1970).
Late sequelae of acute CO intoxications can take very different forms. The symptoms usually involve the central and peripheral nervous systems, less frequently the heart, vessels and internal organs. It is, however, likely that the nervous system symptoms result from vessel damage caused directly by CO.
Long-term continuous or intermittent CO exposure can result in symptoms like those seen in acute intoxications when the CO-Hb level exceeds about 10 %. At lower blood CO-Hb levels (2 -5 %), laboratory studies have revealed reduction in psychosensory and psychomotor abilities; the practical relevance of these findings is controversial (Groll-Knapp et al., 1972; Beard and Wertheim, 1967; Beard and Grandstaff, 1970). In addition, at CO-Hb levels above 5%, ischaemic changes in heart function have been demonstrated experimentally in persons with cardiac disease (Aronow et al., 1972; Anderson et al., 1973; Aronow and Isbell, 1973).
Some habituation to low CO-Hb levels has been demonstrated in heavy smokers and in gas works employees whose average CO-Hb level was 3.8 %. Occasional higher CO-Hb levels, 30-40 %, were not associated with the usual symptoms of intoxication in these workers. It was also possible to produce experimentally a certain resistance to elevated CO-Hb levels by repeated exposure of persons and experimental animals to low CO concentrations. It is not clear whether or not this resistance is simply a result of the increases in haematocrit, Hb and erythrocyte count produced by this treatment (Ray and Rockwell, 1967; Ehrich et al., 1944; Astrup et al., 1967; Wilks et al., 1959).
References:
Anderson EW, Andelman RJ, Strauch JM, Fortuin NJ and Knelson JH (1973). Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris. A study in ten patients with ischemic heart disease. Ann Intern Med 79: 46-50.
Aronow WS and Isbell MW (1973). Carbon monoxide effect on exercise-induced angina pectoris. Ann Intern Med 79: 392-395.
Aronow WS, Harris CN, Isbell MW, Rokaw SN, Imparato B (1972). Effect of freeway travel on angina pectoris. Ann intern Med 77: 669 -676.
Astrup P, Kjeldsen K and Wanstrup J (1967). Enhancing influence of carbon monoxide on the development of atheromatosis in cholesterol-fed rabbits. J Atheroscler Res 7: 343 -354.
Beard RR and Grandstaff N (1970). New York Academy of Science Conference on Biological Effects of Carbon Monoxide. New York City.
Beard RR and Wertheim GA (1967). Behavioral impairment associated with small doses of carbon monoxide. Am J public Health 57: 2012 -2022.
Ehrich WE, Bellet S and Lewey FH (1944). Cardiac changes from CO poisoning. Am J med Sci 208: 512 -523.
Groll-Knapp E, Wagner H, Hauck H and Haider M (1972). Effects of low carbon monoxide concentrations on vigilance and computer-analyzed brain potentials. Staub Reinhalt Luft 32: 64 -68.
Lindgren SA (1961). A study of the effect of protracted occupational exposure to carbon monoxide with special reference to the occurrence of so-called chronic carbon monoxide poisoning. Acta med scand 167 (Suppl. 356): 1 -135.
Ray AM and Rockwell TH (1967). Ohio State University, Dept. of Industrial Engineering Columbus, Ohio. Report Number IE-i.
Stewart RD, Peterson JE, Baretta ED, Bachand RT, Hosko MJ and Herrmann AA. (1970). Experimental human exposure to carbon monoxide. Arch Environ Health 21: 154 -164.
Wilks SS, Tomashefski JF and Clark RT (1959). Physiological effects of chronic exposure to carbon monoxide. J Appl Physiol 14: 305 -310.
Applicant's summary and conclusion
- Executive summary:
A maximum (allowable) concentration at the workplace (MAK value) of 30 mL/m³ (35 mg/m³) was defined for CO (DFG, 1992). This value is based on data obtained with non-smokers and does not apply for pregnant women. With regard to short term-exposure to CO, a value of 30 mL/m³ was indicated (DFG, 2001).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.